Sein Adjuvant MEDEA Motivating to Exercise and Diet, and Educating to healthy behaviors After breast cancer (MEDEA). Paris PAUL-HENRI COTTU
Appareil pulmonaire TROPION-Lung01 (DS1062-A-U301) PHASE 3 RANDOMIZED STUDY OF DS-1062A VERSUS;DOCETAXEL IN PREVIOUSLY TREATED ADVANCED;OR METASTATIC NON-SMALL CELL LUNG CANCER;WITHOUT ACTIONABLE GENOMIC ALTERATIONS;(TROPION-LUNG01) Paris NICOLAS GIRARD
Appareil pulmonaire TROPION-Lung05 (DS1062-A-U202) Phase 2, Single-arm, Open-label Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations and Progressed on or After Kinase Inhibitor Therapy and Platinum Based Chemotherapy (TROPION-Lung05) Paris NICOLAS GIRARD
Gynécologie - Ovaires AGO-OVAR 2.29 Atezolizumab in combination with Bevacizumab and Chemotherapy;versus Bevacizumab and Chemotherapy;in recurrent ovarian cancer À a randomized Phase III trial;An ENGOT Trial Paris MANUEL RODRIGUES
Recherches "plusieurs pathologies" TG4001.12 A phase Ib/II trial evaluating the combination of TG4001 and avelumab in patients with HPV-16 positive recurrent or metastatic malignancies and expansion cohort to oropharyngeal squamous cell carcinoma of the head and neck (SCCHN) Paris CHRISTOPHE LE TOURNEAU